281 related articles for article (PubMed ID: 17196388)
1. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
Mai A; Rotili D; Massa S; Brosch G; Simonetti G; Passariello C; Palamara AT
Bioorg Med Chem Lett; 2007 Mar; 17(5):1221-5. PubMed ID: 17196388
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
[TBL] [Abstract][Full Text] [Related]
3. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
[TBL] [Abstract][Full Text] [Related]
4. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans.
Simonetti G; Passariello C; Rotili D; Mai A; Garaci E; Palamara AT
FEMS Yeast Res; 2007 Dec; 7(8):1371-80. PubMed ID: 17627775
[TBL] [Abstract][Full Text] [Related]
6. Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds.
Trabocchi A; Mannino C; Machetti F; De Bernardis F; Arancia S; Cauda R; Cassone A; Guarna A
J Med Chem; 2010 Mar; 53(6):2502-9. PubMed ID: 20184325
[TBL] [Abstract][Full Text] [Related]
7. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
Yücesoy M; Marol S
Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the trailing endpoint observed in Candida albicans susceptibility testing using the CLSI procedure.
Coenye T; De Vos M; Vandenbosch D; Nelis H
Clin Microbiol Infect; 2008 May; 14(5):495-7. PubMed ID: 18341604
[TBL] [Abstract][Full Text] [Related]
9. Effect of chemosensitizers on minimum inhibitory concentrations of fluconazole in Candida albicans.
Bulatova NR; Darwish RM
Med Princ Pract; 2008; 17(2):117-21. PubMed ID: 18287794
[TBL] [Abstract][Full Text] [Related]
10. Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure-activity relationships of (N-methyl-piperazinyl)-containing derivatives.
Watkins WJ; Lemoine RC; Chong L; Cho A; Renau TE; Kuo B; Wong V; Ludwikow M; Garizi N; Iqbal N; Barnard J; Jankowska R; Singh R; Madsen D; Lolans K; Lomovskaya O; Oza U; Dudley MN
Bioorg Med Chem Lett; 2004 Oct; 14(20):5133-7. PubMed ID: 15380214
[TBL] [Abstract][Full Text] [Related]
11. Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.
Arai R; Sugita T; Nishikawa A
Mycoses; 2005 Jan; 48(1):38-41. PubMed ID: 15679664
[TBL] [Abstract][Full Text] [Related]
12. The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.
Shi W; Chen Z; Chen X; Cao L; Liu P; Sun S
FEMS Yeast Res; 2010 Nov; 10(7):885-93. PubMed ID: 20707818
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?
Ribeiro MA; Paula CR
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):71-5. PubMed ID: 16839736
[TBL] [Abstract][Full Text] [Related]
15. Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans.
Endo EH; Cortez DA; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
Res Microbiol; 2010 Sep; 161(7):534-40. PubMed ID: 20541606
[TBL] [Abstract][Full Text] [Related]
16. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
Bruzual I; Riggle P; Hadley S; Kumamoto CA
J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
[TBL] [Abstract][Full Text] [Related]
17. Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle.
Zore GB; Thakre AD; Jadhav S; Karuppayil SM
Phytomedicine; 2011 Oct; 18(13):1181-90. PubMed ID: 21596542
[TBL] [Abstract][Full Text] [Related]
18. [Fluconazole resistance in Candida albicans assayed by PCR fingerprinting with M13 prime].
Wang YB; Wang H; Guo HY; Zhao YZ; Luo SQ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1303-6. PubMed ID: 14678897
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors for enhancing activity of antifungal agent: a patent evaluation of WO2014041424(A1).
Zhang L; Xu W
Expert Opin Ther Pat; 2015 Feb; 25(2):237-40. PubMed ID: 25381141
[TBL] [Abstract][Full Text] [Related]
20. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
